Published in PLoS One on May 05, 2014
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology (2015) 1.21
Biomarkers of Parkinson's disease: present and future. Metabolism (2014) 1.14
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget (2015) 0.87
microRNA-Based Biomarkers and the Diagnosis of Alzheimer's Disease. Front Neurol (2015) 0.83
microRNA Profiles in Parkinson's Disease Prefrontal Cortex. Front Aging Neurosci (2016) 0.83
The Identification of Circulating MiRNA in Bovine Serum and Their Potential as Novel Biomarkers of Early Mycobacterium avium subsp paratuberculosis Infection. PLoS One (2015) 0.82
Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome. Learn Mem (2016) 0.80
Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol (2016) 0.79
miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study. Transl Neurodegener (2016) 0.78
The MiRNA Journey from Theory to Practice as a CNS Biomarker. Front Genet (2016) 0.78
MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy. Mol Neurobiol (2016) 0.78
Biomarkers in Parkinson's disease: Advances and strategies. Parkinsonism Relat Disord (2015) 0.77
Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease. Front Cell Neurosci (2015) 0.77
MicroRNA expression profiles differentiate chronic pain condition subtypes. Transl Res (2015) 0.77
Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease. J Parkinsons Dis (2016) 0.76
MiR-144-3p and Its Target Gene β-Amyloid Precursor Protein Regulate 1-Methyl-4-Phenyl-1,2-3,6-Tetrahydropyridine-Induced Mitochondrial Dysfunction. Mol Cells (2016) 0.76
MicroRNAs in Parkinson's disease. Exp Brain Res (2017) 0.76
MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian. Oncotarget (2016) 0.75
Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis. Front Aging Neurosci (2016) 0.75
NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. Fluids Barriers CNS (2017) 0.75
MicroRNA-511 Binds to FKBP5 mRNA, Which Encodes a Chaperone Protein, and Regulates Neuronal Differentiation. J Biol Chem (2016) 0.75
Survey of 800+ datasets from human tissue and body fluid reveals XenomiRs are likely artifacts. RNA (2017) 0.75
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects. Oncotarget (2017) 0.75
Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review. Front Mol Neurosci (2016) 0.75
Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease. Front Cell Neurosci (2017) 0.75
Differential expression analysis for sequence count data. Genome Biol (2010) 64.56
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
A MicroRNA feedback circuit in midbrain dopamine neurons. Science (2007) 8.33
A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief Bioinform (2012) 6.06
miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res (2011) 5.83
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A (2008) 5.24
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) (2011) 4.64
A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature (2010) 4.39
Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis (2008) 3.84
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport (2007) 3.70
Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci (2006) 3.41
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature (2010) 3.41
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proc Natl Acad Sci U S A (2013) 3.33
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet (2008) 3.27
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol (2009) 2.67
Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci U S A (2009) 2.61
DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol (2004) 2.51
microRNA-34c is a novel target to treat dementias. EMBO J (2011) 2.44
Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One (2010) 2.26
Understanding microRNAs in neurodegeneration. Nat Rev Neurosci (2009) 2.22
Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol (2002) 2.17
Neuropathologic substrates of Parkinson disease dementia. Ann Neurol (2012) 2.10
A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol (2013) 1.99
Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem (2007) 1.99
MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet (2011) 1.92
miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A (2010) 1.83
miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res (2012) 1.76
miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) (2010) 1.76
Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol (2010) 1.71
Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) (2012) 1.61
Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing. RNA (2013) 1.56
Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med (2013) 1.54
Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol (2011) 1.49
α-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci (2010) 1.49
MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio (2007) 1.43
The complexity of the mammalian transcriptome. J Physiol (2006) 1.43
miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol Cell Biol (2010) 1.43
Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.39
MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther (2011) 1.37
Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One (2010) 1.37
MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem (2010) 1.33
microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol (2012) 1.31
MicroRNAs in Alzheimer's disease. Neurobiol Dis (2012) 1.31
Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol (2012) 1.26
MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res (2010) 1.25
miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci (2012) 1.21
MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol Aging (2010) 1.20
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease. PLoS One (2011) 1.19
Dysregulated microRNAs in neurodegenerative disorders. Semin Cell Dev Biol (2010) 1.19
Identification of blood microRNAs associated to Parkinsonĭs disease. J Biotechnol (2011) 1.13
MicroRNAs in Parkinson's disease. Neurobiol Dis (2012) 1.11
MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet (2012) 1.11
MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Res (2010) 1.11
Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol (2013) 1.09
Plasma-based circulating MicroRNA biomarkers for Parkinson's disease. J Parkinsons Dis (2012) 1.09
Non-coding RNAs in Alzheimer's disease. Mol Neurobiol (2012) 1.08
MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease. Exp Neurol (2011) 1.08
MicroRNAs: possible role in pathogenesis of Parkinson's disease. Biochemistry (Mosc) (2012) 1.04
Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett (2002) 1.04
In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem (2010) 1.03
Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases. Aging (Albany NY) (2010) 1.00
The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. Toxicol Lett (2011) 0.99
Neurofilamentopathy in neurodegenerative diseases. Open Neurol J (2011) 0.96
Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways. Front Genet (2013) 0.94
MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1. Brain Res Bull (2012) 0.93
Opposing actions of environmental enrichment and Alzheimer's disease on the expression of hippocampal microRNAs in mouse models. Transl Psychiatry (2013) 0.90
MicroRNA and proteome expression profiling in early-symptomatic α-synuclein(A30P)-transgenic mice. Proteomics Clin Appl (2008) 0.88
Oxidative stress mediated-alterations of the microRNA expression profile in mouse hippocampal neurons. Int J Mol Sci (2012) 0.88
Diagnostic value of minor salivary glands biopsy for the detection of Lewy pathology. Neurosci Lett (2013) 0.87
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects. Neurol Res (2012) 0.87
Comparison of Analysis Tools for miRNA High Throughput Sequencing Using Nerve Crush as a Model. Front Genet (2013) 0.85
Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament. J Neuroimmunol (2012) 0.83
Role of Personalized Medicine in the Identification and Characterization of Parkinson's Disease in Asymptomatic Subjects. J Alzheimers Dis Parkinsonism (2012) 0.76